Related references
Note: Only part of the references are listed.LRRK2 secretion in exosomes is regulated by 14-3-3
Kyle B. Fraser et al.
HUMAN MOLECULAR GENETICS (2013)
Universal Quantitative Kinase Assay Based on Diagonal SCX Chromatography and Stable Isotope Dimethyl Labeling Provides High-definition Kinase Consensus Motifs for PKA and Human Mps1
Marco L. Hennrich et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Phosphorylation of LRRK2: from kinase to substrate
Evy Lobbestael et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations
Ryan D. Mills et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Synergistic Binding of the Phosphorylated S233-and S259-Binding Sites of C-RAF to One 14-3-3ζ Dimer
Manuela Molzan et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
Nicolas Dzamko et al.
PLOS ONE (2012)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
Etsuro Ohta et al.
FEBS LETTERS (2011)
Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
Philip J. Webber et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
Veronique Daniels et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
Xianting Li et al.
PLOS ONE (2011)
14-3-3 proteins in neurodegeneration
Petra Steinacker et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
14-3-3 proteins as potential therapeutic targets
Jing Zhao et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease
Wongi Seol
BMB REPORTS (2010)
Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Christian Johannes Gloeckner et al.
JOURNAL OF PROTEOME RESEARCH (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
Pooja P. Pungaliya et al.
PLOS ONE (2010)
Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity
Susanne Zach et al.
PLOS ONE (2010)
Investigation of leucine-rich repeat kinase 2
Vasanti S. Anand et al.
FEBS JOURNAL (2009)
It takes two to tango: regulation of G proteins by dimerization
Raphael Gasper et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Clinical features of LRRK2 parkinsonism
Kristoffer Haugarvoll et al.
PARKINSONISM & RELATED DISORDERS (2009)
A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes
Christian Johannes Gloeckner et al.
PROTEOMICS (2007)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
Genta Ito et al.
BIOCHEMISTRY (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
LRRK2 in Parkinson's disease: protein domains and functional insights
Ignacio F. Mata et al.
TRENDS IN NEUROSCIENCES (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity
N Giles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases
PV Nguyen et al.
PROGRESS IN NEUROBIOLOGY (2003)
Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259
AS Dhillon et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Phosphorylation of stargazin by protein kinase A regulates its interaction with PSD-95
J Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis
MB Yaffe
FEBS LETTERS (2002)
Physiological substrates of cAMP-dependent protein kinase
JB Shabb
CHEMICAL REVIEWS (2001)
Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting
MD Ehlers
NEURON (2000)
BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival
Y Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
